FDA inspection
Sri Krishna Pharmaceuticals Limited - Unit IV: FDA inspection ending Aug 4, 2023
FDA inspection 1217382 · Official Action Indicated (OAI) · Sangareddy
Key facts
| Inspection ID | 1217382 |
|---|---|
| Firm | Sri Krishna Pharmaceuticals Limited - Unit IV |
| FEI number | 3005408438 |
| Address | Survey 296/7/10 Ida Bollaram, Jinnaram Mandal |
| City | Sangareddy |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Aug 4, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data